ACTIVE

Newton Biocapital I, pricaf privée de droit belge

Financial year 2025 · Closed on 31/12/2025

Net result-5,3 M €+71,6 %over 1 year

Gross margin-1,4 M €+20,6 %over 1 year

Equity59,5 M €+1,3 %over 1 year

Identity

Source · BCE/KBO

Newton Biocapital I, pricaf privée de droit belge is a Public limited company incorporated in 2017. Its registered office is in Woluwe-Saint-Pierre.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0674.831.275
Incorporation: 25/04/2017
Legal form: Public limited company
Registered office: Avenue de Tervueren 273
1150 Woluwe-Saint-Pierre · BruxellesSee on map
Contributed capital: 99 896 132,34 €
Latest accounts: 31/12/2025

Signals

Solid equityLow riskGood liquidity

Financials

Source · NBB, 10 filings

Trend over 8 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	-1,4 M €	+20.6%	-1,8 M €	-0.9%	-1,8 M €	+26.8%	-2,4 M €	+2.7%	-2,5 M €
EBITDA	-1,4 M €	+20.6%	-1,8 M €	-0.9%	-1,8 M €	+54.1%	-3,9 M €	-1.0%	-3,9 M €
Operating result	-1,4 M €	+20.6%	-1,8 M €	-0.9%	-1,8 M €	+54.1%	-3,9 M €	-1.0%	-3,9 M €
Net result	-5,3 M €	+71.6%	-18,7 M €	-2159%	909,3 k €	+126%	-3,4 M €	+9.5%	-3,8 M €
Balance sheet
Equity	59,5 M €	+1.3%	58,7 M €	-18.2%	71,7 M €	+9.5%	65,5 M €	+26.2%	51,9 M €
Total assets	59,5 M €	+1.3%	58,8 M €	-18.1%	71,8 M €	+9.5%	65,6 M €	+26.2%	52 M €
Cash	496,2 k €	+83.6%	270,3 k €	-95.4%	5,8 M €	-25.1%	7,8 M €	+37.9%	5,7 M €
Debts	44,8 k €	-41.9%	77 k €	+20.7%	63,9 k €	-17.8%	77,7 k €	+0.5%	77,3 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

7 active · 6 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
JCO Consulting0693.684.414Represented by Jean Combalbert	Director22/01/2025 → 28/05/2027
DAB Management0811.829.622Represented by Dirk BOOGMANS	Director07/02/2018 → 28/05/2027
Michihiko WADA	Director26/05/2020 → 28/05/2027
SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT0253.445.063Represented by François FONTAINE	Director21/04/2017 → 28/05/2027
SPARAXIS0452.116.307Represented by Sophie SAUVAGE	Director15/12/2017 → 28/05/2027
SUNATHIM0474.893.093Represented by Ajit SHETTY	Director21/04/2017 → 28/05/2027
Newton Biocapital Partners0673.852.565Represented by Alain PARTHOENS	Personne déléguée à la gestion journalièresince 26/04/2017

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Robert HIRST	Director25/05/2021 → 21/01/2025
Christophe DEMAIN	Director21/05/2021 → 28/05/2024

Other companies at this address

Avenue de Tervueren 273 1150 Woluwe-Saint-Pierre

Company	CBE no.
A.C.P. AV TERVUREN 273 1150 WOLUWE ST PIERRE● Active	0850.679.013
Affix Corporate Finance● Active	0861.703.557
A Q INVEST● Active	0892.924.986
AQ PARTNERS● Active	0502.699.431
BELGIAN RISK MANAGEMENT ASSOCIATION● Active	0414.101.611
BONHIVERS- AVOCATS - ADVOCATEN - LAWYERS● Active	0726.424.387
CYRILLE BARETTE-AVOCAT● Active	0886.316.021
European Coil Coating Association● Active	0414.448.930
FEDERATION EUROPEENNE DE RISK MANAGEMENT - FEDERATION OF EUROPEAN RISK MANAGEMENT ASSOCIATIONS● Active	0414.927.002
HDI Global Belgium VAT Unit● Active	0746.998.681
JERSERAV● Active	1036.688.092
LATOUR● Active	0507.666.128
LATOUR & PETIT● Active	0475.331.474
LES AMIS D'ISAAC● Active	0743.763.831
L&P MANAGEMENT● Active	1035.538.940
Madyol● Active	0691.614.552
Newton Biocapital II● Active	0779.335.513
Newton Biocapital I Investment Pool● Active	0685.758.425
Newton Biocapital II Partners● Active	0767.828.541
Newton Biocapital Partners● Active	0673.852.565

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	01/06/2026	29/07/2025	24/07/2024	24/05/2023	10/08/2022	19/08/2021
General meeting	26/05/2026	27/05/2025	28/05/2024	23/05/2023	24/05/2022	25/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 10 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	26/05/2026	01/06/2026	French	PDF
Abridged model	31/12/2024	27/05/2025	29/07/2025	French	PDF
Abridged model	31/12/2023	28/05/2024	24/07/2024	French	PDF
Abridged model	31/12/2022	23/05/2023	24/05/2023	French	PDF
Abridged model	31/12/2021	24/05/2022	10/08/2022	French	PDF
Abridged model	31/12/2020	25/05/2021	19/08/2021	French	PDF
Abridged model	31/12/2019	27/05/2020	03/06/2020	French	PDF
Abridged modelCorrection	31/12/2018	21/05/2019	10/04/2020	French	PDF
Abridged model	31/12/2018	21/05/2019	06/06/2019	French	PDF
Abridged model	31/12/2017	15/05/2018	07/06/2018	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

7 active · 6 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
JCO Consulting0693.684.414Represented by Jean Combalbert	Director22/01/2025 → 28/05/2027
DAB Management0811.829.622Represented by Dirk BOOGMANS	Director07/02/2018 → 28/05/2027
Michihiko WADA	Director26/05/2020 → 28/05/2027
SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT0253.445.063Represented by François FONTAINE	Director21/04/2017 → 28/05/2027
SPARAXIS0452.116.307Represented by Sophie SAUVAGE	Director15/12/2017 → 28/05/2027
SUNATHIM0474.893.093Represented by Ajit SHETTY	Director21/04/2017 → 28/05/2027
Newton Biocapital Partners0673.852.565Represented by Alain PARTHOENS	Personne déléguée à la gestion journalièresince 26/04/2017

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Robert HIRST	Director25/05/2021 → 21/01/2025
Christophe DEMAIN	Director21/05/2021 → 28/05/2024

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

14/09/2026
—
PDF
Other05/06/2026
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates23/02/2026
DEMISSIONS, NOMINATIONS
PDF
Mandates13/01/2026
DEMISSIONS, NOMINATIONS
PDF
Mandates23/07/2025
DEMISSIONS, NOMINATIONS
PDF
Capital / shares28/04/2025
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
PDF
Mandates15/04/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates07/04/2025
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings8 filings

Mandates

JCO Consulting

SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT

SPARAXIS

SUNATHIM

DAB Management

Michihiko WADA

Newton Biocapital Partners

Robert HIRST

Christophe DEMAIN

SK MANAGEMENT LTD

Ko Sekiguchi

GEMA

and 1 more mandate

20172018201920202021202220232024202520262027

Newton Biocapital I, pricaf privée de droit belge

Avenue de Tervueren 273, 1150 Woluwe-Saint-Pierre

Director

Personne déléguée à la gestion journalière

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Avenue de Tervueren 273, 1150 Woluwe-Saint-PierreCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00138524

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
Newton Biocapital I, pricaf privée de droit belgeCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00138524

Events

2025
Annual accounts 2025-5,3 M €↑
24/04/2025
reduction_capital
22/01/2025
nominationJCO Consulting SRL · Administrateur
22/01/2025
nominationJCO Consulting SRL, représentée par M. Jean Combalbert · Administrateur indépendant
2024
Annual accounts 2024-18,7 M €↓
2023
Annual accounts 2023909,3 k €↑
23/05/2023
reconductionJulie Delforge · Commissaire
28/03/2023
nominationSophie Sauvage · Administrateur
15/02/2023
reduction_capital
2022
Annual accounts 2022-3,4 M €↑
2021
Annual accounts 2021-3,8 M €↑
2020
Annual accounts 2020-4,3 M €↓
2018
Annual accounts 2018-1,8 M €↓
2017
Annual accounts 2017-1,1 M €
25/04/2017
IncorporationPublic limited company

Newton Biocapital I, pricaf privée de droit belge

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events